The Amifampridine Table, cataloged under National Stock Number 6505-01-686-6357, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Jacobus Pharmaceutical Co. Inc.. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-686-6357 |
| Primary Part Number | NDC49938-0110-01 |
| Item Name | Amifampridine Table |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Jacobus Pharmaceutical Co. Inc. |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC49938-0110-01 PRIMARY | Jacobus Pharmaceutical Co. Inc. (USA) |
| Reference | Meaning |
|---|---|
| 1567866 | 5/1 Secondary reference U.S. Government activity |
| RUZURGI | 5/1 Secondary reference Jacobus Pharmaceutical Co. Inc. |
| 6505NCM205934 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-686-6357 is a Amifampridine Table, manufactured by Jacobus Pharmaceutical Co. Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-686-6357 has 1 manufacturer part number on file: NDC49938-0110-01 (Jacobus Pharmaceutical Co. Inc.).
Key specifications for NDC49938-0110-01: Special Features: POTASSIUM CHANNEL BLOCKER INDICATED FOR THE TREATMENT OF LAMBERT-EATON MATON MYASTHENIC SYNDROME (LEM) IN PATIENTS 6 TO LESS THAN 17 YEARS OF AGE; TABLETS ARE OVAL, WHITE TO OFF WHITE, AND DEBOSSED "10/110" ON ONE SIDE AND "JACOBUS" ON THE OTHER SIZE; BOTTLE OF 100 TABLETS; PRIOR TO DISPENSING STORE TABLETS IN A REFRIGERATOR BETWEEN 2C TO 8C (36F TO 46F), KEEP CONTAINER TIGHTLY CLOSED WITH DESICCANT CANISTER INSIDE AFTER OPENING; PROTECT FROM MOISTURE AND LIGHT; AFTER DISPENSING STORE TABLETS AT 20C TO 25C (68F TO 77F) FOR UP TO 3 MONTHS; EXCURSIONS PERMITTED BETWEEN 15C TO 30C (59F TO 86F) SEE USP CONTROLLED ROOM TEMPERATURES; POTENTIAL TREATMENT FOR BOTULINUM BOTULISM (BOT) NEUROTOXIN (TOXIN); RUZURGI CAN BE TAKEN WITHOUT REGARD TO FOOD.; Part Name Assigned by Controlling Agency: AMIFAMPRIDINE TABLETS, 10MG, 100S. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.